Literature DB >> 4009601

Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives.

D A Marsh, H J Brodie, W Garrett, C H Tsai-Morris, A M Brodie.   

Abstract

The synthesis and biological evaluation of androstenedione derivatives as inhibitors of estrogen biosynthesis are described. The results show that 4-hydroxy analogues are among the most potent in vitro inhibitors of the series. Esterification of the 4-hydroxy steroids generally reduced activity. Further conjugation of the 3-keto 4-ene system to give 4-hydroxy-4,6-androstadiene-3,17-dione caused more rapid inactivation of aromatase in rat ovarian microsomes than 4-hydroxyandrostenedione. Some compounds exhibited differences in activity when tested for inhibition of human placental microsomes vs. rat ovarian microsomes. The 4-hydroxyandrostenedione derivatives and their nonbulky esters were generally more potent in vitro and in vivo inhibitors than other substituted steroids in the series. Several of the synthesized compounds markedly reduce (50-81%) estrogen levels in rats on proestrus and/or had antifertility action. To date, none of the compounds surpassed the in vivo inhibitory action of 4-hydroxy-4-androstene-3,17-dione or its 4-acetate derivative.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009601     DOI: 10.1021/jm00383a017

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  Aromatase inhibitors--mechanisms of steroidal inhibitors.

Authors:  R W Brueggemeier
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

2.  Design and synthesis of new steroidal inhibitors of estrogen synthase (aromatase).

Authors:  E J Parish; S Li; Z Rao
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

3.  Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells.

Authors:  N Harada; O Hatano
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

Review 4.  Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.

Authors:  L R Wiseman; D McTavish
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

5.  Variation in aromatase activity in the medial preoptic area and plasma progesterone is associated with the onset of paternal behavior.

Authors:  Brian C Trainor; Ian M Bird; Noel A Alday; Barney A Schlinger; Catherine A Marler
Journal:  Neuroendocrinology       Date:  2003-07       Impact factor: 4.914

Review 6.  Aromatase and its inhibitors in breast cancer treatment--overview and perspective.

Authors:  A M Brodie; R J Santen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 7.  Successful Targeted Therapies for Breast Cancer: the Worcester Foundation and Future Opportunities in Women's Health.

Authors:  Balkees Abderrahman; V Craig Jordan
Journal:  Endocrinology       Date:  2018-08-01       Impact factor: 4.736

Review 8.  Bismuth(III) reagents in steroid and terpene chemistry.

Authors:  Jorge A R Salvador; Samuel M Silvestre; Rui M A Pinto
Journal:  Molecules       Date:  2011-04-04       Impact factor: 4.411

Review 9.  Modulation of Aromatase by Phytoestrogens.

Authors:  Edwin D Lephart
Journal:  Enzyme Res       Date:  2015-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.